BTG CASE STUDIES > MARKET ACCESS

Market Access Sales Training and Support

The pharmaceutical reimbursement landscape has grown increasingly complex and—thanks to an intensifying focus on improving clinical outcomes—increasingly competitive. Reimbursement was once a formality that followed regulatory approval. Now, it’s forcing life science companies to rethink their market access strategies and reorganize the way they develop…

READ MORE


Market Access Innovations: Pharmaceutical Affordability

Affordability is a major concern in health and life science—and not just in the U.S. In 2018, total prescription drug expenditure in the U.S. is expected to top $520 billion; 52% of Americans say bringing down the price of prescription drugs should be a “top…

READ MORE


Commercializing A Breakthrough Medicine

A major biopharmaceutical company had developed a breakthrough medication that stood to dramatically disrupt the market for its therapeutic area. Expected to be approved by the FDA in the next year or two, this new drug had the potential to bring billions of dollars upon…

READ MORE


Pricing and Tender Strategy

The head of the medical products division at a F200 healthcare company was concerned about stagnating profits in the U.S. She had identified 15 different countries that presented growth opportunities, but needed help crafting market access plans and pricing models. Unable to add permanent headcount,…

READ MORE


Accelerating an Oncology Drug Launch

A F300 pharma company was preparing to launch a new oncology drug. But its understaffed pricing and market access group was struggling to create global access plans and strategies. Expecting accelerated regulatory approvals in the US and Europe, the company’s Director of Global Pricing turned…

READ MORE


Oncology Market Access Support

The lean market access group at a global pharma company was preparing to launch a recently acquired pipeline oncology asset. Yet they were struggling to coordinate US payer marketing activities. Looking for additional expertise in oncology market access, they turned to Business Talent Group. Our…

READ MORE


Assessing an Acquisition’s Market Access Potential

A multi-million-dollar pharmaceutical company was in talks to acquire an orphan drug manufacturer with a pipeline asset that was about to launch in Europe. The company’s corporate development team was focused on the deal’s financials, but they lacked the expertise to assess the access potential…

READ MORE


Send this to a friend